FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

11 letters match. Newest first.

  1. Prodose, Inc. formerly known as Spirit Pharmaceuticals LLC

    Prodose, formerly Spirit Pharmaceuticals, left a cold and flu drug mislisted; FDA calls it misbranded.

    Low
  2. Zen Enterprises LLC

    Zen Enterprises failed to correct drug listing files that named a manufacturer not involved in making its balms and hand sanitizers.

    Low
  3. Dr Sankunni’s Ayurvedic Research Foundation Private Ltd.

    Dr Sankunni's Ayurvedic Research Foundation failed to correct drug listing and registration errors for its balms and hand sanitizer.

    Low
  4. Walgreen Company

    FDA warns Walgreen Company that its Walgreens Sensitive Extra Whitening drug listing is incomplete and inaccurate.

    Low
  5. Lydia Co. Ltd.

    Lydia Co. Ltd. submitted mismatched drug listing data for eight products, leading FDA to remove them from its NDC Directory.

    Low
  6. Procter & Gamble Manufactura S. de R.L. de C.V.

    FDA warned P&G Manufactura over mismatched active ingredients in the drug listing for Vicks Nyquil Severe Hot Remedy.

    Low
  7. Unit Dose Services, LLC

    Unit Dose Services of Miami, Florida, listed Lisinopril with a carton label image showing a different drug, acetaminophen.

    Low
  8. Grimann S.A. de C.V.

    FDA warns Grimann over Derofen Miel drug listing with contradictory active ingredients, label image, and package size.

    Low
  9. ECI Pharmaceuticals, LLC

    ECI Pharmaceuticals listed conjugated estrogens instead of esterified estrogens for two drugs, FDA says.

    Low
  10. ECI Pharmaceuticals, LLC

    FDA warned ECI Pharmaceuticals for listing the wrong active ingredient for its estrogen and testosterone drugs, which got them removed from the NDC Directory.

    Low
  11. RPK Pharmaceuticals Inc.

    RPK Pharmaceuticals sent FDA a mismatched label for clotrimazole and betamethasone dipropionate cream in its drug listing.

    Low